Key Takeaway: Vivani Medical has announced a business update that includes securing $5 million in equity financing. Additionally, the company has reported its financial results for the third quarter of 2024. This funding is expected to support the company's ongoing projects and initiatives.
Price reaction · baseline $1.25 (2024-11-12 close) · hit pre-market · clean, no other VANI news in the window
day 0 close
+11.2%
day 1 · peak
+15.2%
day 3
+5.6%
Market Sentiment Analysis
POSITIVE FACTORS
Vivani Medical secured $5M in equity financing.
The company has reported its financial results for Q3 2024.
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial advice
Cash runway
~10 mo
Medium dilution risk
Lead asset
Semaglutide
Phase 1 · Obesity & Overweight
Full Press Release Details
Blog Post
| November 13, 2024
Vivani Medical Provides Business Update Including $5M Equity Financing and Reports Third Quarter 2024 Financial Results
Read More
Previous Article
Next Article
Blog Navigation
Frequently Asked Questions
What financing did Vivani Medical secure?
Vivani Medical secured $5 million in equity financing.
What financial results did Vivani report?
Vivani Medical reported its financial results for the third quarter of 2024.